UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVALFROM LISTING

AND/OR REGISTRATION UNDER SECTION 12(b)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-41058

VAXXINITY,INC.

The Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter,and name of Exchange where security is listed and/or registered)

505 Odyssey Way

Merritt Island, Florida 32953

(254) 244-5739

(Address, including zip code, and telephone number, including area code, of Issuer's principal executiveoffices)

Class A common stock, par value $0.0001 per share

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strikethe class of securities from listing and registration:

☐

17 CFR 240.12d2-2(a)(1)

☐

17 CFR 240.12d2-2(a)(2)

☐

17 CFR 240.12d2-2(a)(3)

☐

17 CFR 240.12d2-2(a)(4)

☐

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strikethe class of securities from listing and/or

withdraw registration on the Exchange.

☒

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules ofthe Exchange and the requirements of 17 CFR

240.12d-2(c) governing the voluntary withdrawal of the class of securities fromlisting and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, Vaxxinity,Inc. certifies that it has reasonable

grounds to believe that it meets all of the requirements for filing the Form 25 and has causedthis notification to be signed on its behalf

by the undersigned duly authorized person.

April 29, 2024

By

/s/ Mei Mei Hu

Chief Executive Officer

Date

Name

Title